Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00308308 · ClinicalTrials.gov registry record · Phase 3
Efficacy & Safety of Inhaled Insulin in Type 1 Diabetes
A Phase 3 study, sponsored by Mannkind Corporation.
- Completed
- Registry status
- Phase 3
- Development phase
- 589
- Enrollment target
NCT00308308 is a Phase 3 study that has completed, run by Mannkind Corporation. The registered enrollment target is 589 participants.
The verdict
NCT00308308, a Phase 3 study, has completed, sponsored by Mannkind Corporation.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 589 participants
- Enrollment target
Study Summary
To determine the safety and efficacy of inhaled insulin in the treatment of type 1 diabetes
Interventions
- DRUG Technosphere Insulin
- DRUG Active comparator
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 589 participants |
| Start Date | 2006-02 |
| Est. Completion | 2008-08 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00308308
The ClinicalTrials.gov registry entry for NCT00308308 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 589 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mannkind Corporation, which has 42 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Technosphere Insulin is the first listed.
NCT00308308 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00308308 about?
NCT00308308 is a clinical study titled "Efficacy & Safety of Inhaled Insulin in Type 1 Diabetes". To determine the safety and efficacy of inhaled insulin in the treatment of type 1 diabetes
What is the current status of trial NCT00308308?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 589 participants. The study started on 2006-02. Estimated completion is 2008-08.
What interventions are being tested in trial NCT00308308?
The interventions under investigation include: Technosphere Insulin (DRUG), Active comparator (DRUG).
Who is sponsoring clinical trial NCT00308308?
This trial is sponsored by Mannkind Corporation, which has 42 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.